Expanded access

Oct 21, 2019

Beacon of Hope CRO Changes Name to Access Hope CRO

Sep 12, 2019

Beacon of Hope CRO Launches at ALS Association Florida Chapter's Sixth Annual Hope and Help Symposium

Jun 03, 2019

FDA announces Project Facilitate to assist physicians seeking access to unapproved therapies for patients with cancer

Mar 29, 2019

Statement by FDA Commissioner Scott Gottlieb, M.D., Director of FDA's Center for Drug Evaluation and Research Janet Woodcock, M.D. and Director of FDA's Center for Biologics Evaluation and Research Peter Marks, M.D. on Expanded Access -Looking Forward

Nov 08, 2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on new efforts to strengthen FDA's expanded access program

Oct 26, 2018

Q BioMed Takes the Stage in the Expanded Access Debate at European Early and Managed Access Program Conference

May 31, 2018

Expanded Access Summit Returns to Boston September 6th and 7th

May 30, 2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on the signing of the Right to Try Act

Apr 09, 2018

Bionical Group Ltd. Today Announces the Launch of Bionical-Clinical Early Access Programs (EAP)

Nov 15, 2017

FDA approves treatment for rare genetic enzyme disorder

Jul 31, 2017

76% of Experimental Medicines Provided to Very Ill Patients in Expanded Access Programs Receive FDA Marketing Approval, New Study Finds

May 26, 2017

Two Day Seminar on the FDA's New Import Program for 2017: Strict Precision (Boston, MA, United States - November 9-10, 2017) - Research and Markets